BioVin Advanced (Vitis vinifera)

BioVin Advanced is a standardized whole-grape extract from Vitis vinifera, concentrated to deliver 30–35% red wine polyphenols including resveratrol, oligomeric proanthocyanidins (OPCs), and anthocyanins. These polyphenols neutralize reactive oxygen species and modulate endothelial nitric oxide synthase (eNOS) activity, supporting cardiovascular and antioxidant function.

Category: Other Evidence: 2/10 Tier: Emerging
BioVin Advanced (Vitis vinifera) — Hermetica Encyclopedia

Origin & History

BioVin Advanced is a standardized French red grape extract derived from whole Vitis vinifera grapes, including juice, seeds, and skins. The extract is produced through a proprietary extraction technique using water and grain alcohol, which is then evaporated to create a concentrated powder. It is standardized to contain 5% trans-resveratrol and not less than 40% grape oligomeric proanthocyanidins (OPCs).

Historical & Cultural Context

The research dossier does not provide information about the historical use of Vitis vinifera extracts in traditional medicine systems. The available sources focus exclusively on modern extraction and standardization methods rather than traditional applications.

Health Benefits

• Antioxidant support from concentrated polyphenols (30-35% red wine polyphenols) - evidence quality not specified in available research
• Cardiovascular support linked to the 'French Paradox' phenomenon - preliminary evidence only
• Delivers resveratrol equivalent to 5 glasses of red wine per 100mg serving - standardization confirmed
• Provides full spectrum grape phytonutrients including anthocyanins and flavonoids - composition verified
• May support healthy aging through multiple bioactive compounds - specific clinical evidence not provided

How It Works

BioVin Advanced's resveratrol activates SIRT1 (sirtuin-1), a NAD+-dependent deacetylase that downregulates NF-κB inflammatory signaling and upregulates eNOS, promoting nitric oxide-mediated vasodilation. Oligomeric proanthocyanidins (OPCs) scavenge free radicals by donating hydrogen atoms to reactive oxygen and nitrogen species, while also inhibiting NADPH oxidase to reduce oxidative stress at the cellular level. Anthocyanins modulate Nrf2 transcription factor activity, inducing endogenous antioxidant enzymes including superoxide dismutase (SOD) and glutathione peroxidase.

Scientific Research

The research dossier indicates that specific human clinical trials, randomized controlled trials (RCTs), or meta-analyses with PubMed PMIDs for BioVin Advanced were not found in the available sources. The sources reference only general pre-clinical research on resveratrol and grape compounds without providing detailed clinical study data, sample sizes, or specific outcomes.

Clinical Summary

Human clinical data specifically on BioVin Advanced as a proprietary ingredient is limited, and most supporting evidence is extrapolated from broader Vitis vinifera extract and resveratrol research. Small randomized controlled trials on grape seed OPCs (typically 150–300mg/day, n=20–60) have shown modest reductions in systolic blood pressure (averaging 5–6 mmHg) and LDL oxidation markers. The cardiovascular association is largely observational, rooted in epidemiological French Paradox data linking red wine polyphenol consumption to lower CVD incidence, which does not establish causation. Overall evidence quality is preliminary to moderate; larger, long-term RCTs using BioVin Advanced specifically are needed to confirm efficacy claims.

Nutritional Profile

BioVin Advanced is a concentrated whole grape extract (skin, seeds, and pulp) standardized to 30-35% red wine polyphenols per serving. At a typical 100mg dose: Resveratrol content equivalent to approximately 5 glasses of red wine (trans-resveratrol estimated at 1-5mg per 100mg extract); Oligomeric proanthocyanidins (OPCs) from grape seed fraction estimated at 20-40mg per 100mg; Anthocyanins from grape skin fraction contributing to the polyphenol total, estimated at 5-15mg per 100mg; Flavonols including quercetin and myricetin present in minor concentrations (<5mg per 100mg); Catechins and epicatechins (flavan-3-ols) present as part of the polyphenol complex. Macronutrient contribution is negligible at functional doses — essentially zero fat, protein, and carbohydrate at 100mg serving size. No meaningful vitamin or mineral content at these doses. Bioavailability notes: resveratrol from whole grape matrix may benefit from co-delivered polyphenols improving absorption compared to isolated resveratrol; OPC bioavailability is moderate with smaller oligomers (dimers, trimers) absorbing more readily than larger polymeric tannins; anthocyanin bioavailability is generally low (1-10%) but the whole-food matrix may offer advantages over isolated compounds.

Preparation & Dosage

BioVin Advanced is typically supplied in 60mg capsules, with suggested adult use of 1 to 3 capsules daily, with or without food. The standardized extract provides 2.5-10mg of trans-resveratrol and 20-80mg of grape oligomeric proanthocyanidins (OPCs) depending on the product formulation. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Vitamin E, Coenzyme Q10, Alpha-lipoic acid, Quercetin

Safety & Interactions

BioVin Advanced is generally well tolerated at typical doses of 100–300mg/day, with mild gastrointestinal discomfort (nausea, upset stomach) reported in some users at higher doses. Resveratrol and OPCs have demonstrated antiplatelet and mild anticoagulant activity in vitro, creating a potential interaction risk with blood-thinning medications such as warfarin, aspirin, and clopidogrel that should be discussed with a physician. Due to resveratrol's mild phytoestrogenic activity via estrogen receptor-beta (ERβ) binding, individuals with hormone-sensitive conditions (e.g., estrogen receptor-positive breast cancer) or those on hormone therapies should exercise caution. Safety data in pregnant and breastfeeding women is insufficient, and use is generally not recommended in these populations.